🚧 Will Levis

Will Levis’ struggle with glasses and contacts

As a quarterback for the University of Kentucky Wildcats, Will Levis knew the importance of clear vision. Every move, every pass, and every decision depended on it. But being nearsighted and wearing contact lenses posed challenges that often impacted his game.

“I've had to deal with glasses and contact lenses for my whole adolescent and adult life. I've even had my contact lenses knocked out during a game, taking away my ability during a play or a drive.”

When he was drafted by the Tennessee Titans in 2023, the stakes became even higher. Transitioning to professional football meant he couldn't afford any distractions, especially from his vision.

“I wanted to do what was best for me and have the best edge that I could get. When looking at all the options, it became clear that EVO ICL was the best option for me.”

Why Will Levis chose EVO ICL lenses

When doing his research on EVO ICL, a couple of benefits stood out to Will:

Safety: Unlike other procedures, EVO ICL doesn’t involve the permanent removal of corneal tissue.
Comfort: The EVO ICL procedure doesn't cause dry eye syndrome.
Removability: EVO ICL lenses can be safely removed by a doctor if ever needed. This added flexibility gave Will peace of mind.

“On the field, EVO ICL gives me more confidence in my game and my ability. EVO ICL lets me play more freely, not having to worry about the daily hassles that come with wearing contact lenses.”

“My day-to-day life has changed drastically. Being able to wake up and see clearly right away is such an underrated aspect of life. The difference in my eyesight from before and after the EVO ICL procedure is night and day. I truly know that getting EVO ICL is one of the best decisions I've made in my entire life.”

주요 안전성 정보

ICL은 성인을 대상으로 -0.5D에서 -18.0D 범위의 근시와 6.0D까지의 난시 교정에 대해 승인되었습니다. 21세에서 60세 사이의 성인이 ICL 수술 대상이 됩니다. 안내렌즈삽입술의 성공적인 결과를 위해서는 지난 1년간 시력에 변화가 없어야 합니다. ICL 수술은 안경 및 콘택트렌즈 사용이 필요하지 않도록 시력을 교정합니다. 눈의 노화로 인해 자연적으로 필요한 돋보기 안경은 ICL 안내렌즈삽입술을 받은 후에도 필요할 수 있습니다. ICL은 라식(LASIK), 굴절교정레이저각막절제술(PRK) 및 절개 수술을 포함한 다른 굴절 교정수술법들과 콘택트렌즈 및 안경 등의 시력 교정 방법에 대한 대안이 될 수 있습니다. ICL 안내렌즈삽입술은 외과적 수술이므로 심각한 부작용을 유발할 수도 있습니다. 일반적인 굴절 교정 수술과 관련하여 보고된 발생 가능한 부작용 및 합병증에는 추가적 수술, 백내장 발생, 최대교정시력 손실, 안압 증가, 각막내피세포 손실, 결막 자극, 급성 각막 부종, 지속적 각막 부종, 안내염, 빛번짐, 눈부심, 전방출혈(안구 내 출혈), 전방 축농(안구 내 고름), 염증, 렌즈 탈구, 황반 부종, 동공 무반응, 동공차단 녹내장, 심각한 안내 염증, 홍채염, 포도막염, 유리체 손실 및 각막 이식 등이 있습니다. ICL 수술을 고려하기 전, 정밀 눈 검사를 받은 후 안과 전문의에게 ICL 수술의 장점, 위험요소 및 부작용에 대해 상담 하십시오. 수술 후 회복을 위한 시간에 대해서도 상담하십시오.

참고문헌

참고자료

Home - 광고심의필: 조합-2022-04-030 (유효기간: 2025.02.07)

1. Gonzalo Carracedo, et al. The role of dinucleoside polyphosphates on the ocular surface and other eye structures. Prog Retin Eye Res. 2016 Nov;55:182-205. 2. Paul J Dougherty, et al. Refractive outcomes and safety of the implantable collamer lens in young low-to-moderate myopes. Clin Ophthalmol. 2017;11:273–277. 3. Gregory D. Parkhurst, et al. Phakic Intraocular Lens Implantation in United States Military Warfighters: A Retrospective Analysis of Early Clinical Outcomes of the EVO ICL. J Refract Surg. 2011;27(7);473-481. 4. Feingold et al. Biocompatible, optically transparent, ultraviolet light absorbing, polymeric material based upon collagen and method of making. USPTO June 8, 1999. 5. ICL in Treatment of Myopia (ITM) Study Group. Postoperative Inflammation after Implantation of the Implantable Contact Lens. Ophthalmology 2003;110:2335-2341. 6. Steven Schallhorn, MD et al. Night Driving Simulation in a Randomized Prospective Comparison of Visian Toric Implantable Collamer Lenses and Conventional PRK for Moderate to High Myopic Astigmatism. Journal of Refractive Surgery Vol.26, No. 5, 2010:321-326 7. Gregory D Parkhurst. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clinical Ophthalmology 2016;10:1209-1215. 8. Donald R Sanders et al. United States Food and Drug Administration Clinical Trial of the Implantable Collamer Lens (ICL) for Moderate to High Myopia Three-Year Follow-up. Ophthalmology. 2004;111:1683–1692. 9. Elena Martines-plaze, et al. Effect of the EVO + Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life. Am J Ophthalmol. 2021;226:117-125. 10. Data on file. STAAR Surgical Annual Report.

이보 ICL이란? - 광고심의필: 조합-2022-04-031 (유효기간: 2025.02.07)

1. Feingold et al. Biocompatible, optically transparent, ultraviolet light absorbing, polymeric material based upon collagen and method of making. USPTO June 8, 1999. 2. ICL in Treatment of Myopia (ITM) Study Group. Postoperative Inflammation after Implantation of the Implantable Contact Lens. Ophthalmology 2003;110:2335-2341. 3. Risto J. Uusitalo, et al. Implantable contact lens for high myopia. J Cataract Refract Surg 2002(28):29-36. 4. Gregory D. Parkhurst, et al. Phakic Intraocular Lens Implantation in United States Military Warfighters: A Retrospective Analysis of Early Clinical Outcomes of the EVO ICL. J Refract Surg. 2011;27(7);473-481. 5. FDA. Before, During & After Surgery. https://www.fda.gov/medical-de... (as of 2021-12-24) 6. 윤재문 외. 난시교정용 후방 유수정체 안내렌즈 삽입술의 단기간 임상성적. 대한안과학회지. 2009;50(6):839-851. 7. Steven Schallhorn, MD et al. Night Driving Simulation in a Randomized Prospective Comparison of Visian Toric Implantable Collamer Lenses and Conventional PRK for Moderate to High Myopic Astigmatism. Journal of Refractive Surgery Vol.26, No. 5, 2010:321-326. 8. Gregory D Parkhurst. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clinical Ophthalmology 2016;10:1209-1215. 9. Donald R Sanders et al. United States Food and Drug Administration Clinical Trial of the Implantable Collamer Lens (ICL) for Moderate to High Myopia Three-Year Follow-up. Ophthalmology. 2004;111:1683–1692.

이보 ICL의 장점(야간시력 개선) - 광고심의필: 조합-2022-04-032 (유효기간: 2025.02.07)

1. Steven Schallhorn, MD et al. Night Driving Simulation in a Randomized Prospective Comparison of Visian Toric Implantable Collamer Lenses and Conventional PRK for Moderate to High Myopic Astigmatism. Journal of Refractive Surgery Vol.26, No. 5, 2010:321-326. 2. Gregory D Parkhurst. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clinical Ophthalmology 2016;10:1209-1215. 3. Donald R Sanders et al. United States Food and Drug Administration Clinical Trial of the Implantable Collamer Lens (ICL) for Moderate to High Myopia Three-Year Follow-up. Ophthalmology. 2004;111:1683–1692. 4. FDA. Before, During & After Surgery. https://www.fda.gov/medical-de... (as of 2021-12-24) 5. 윤재문 외. 난시교정용 후방 유수정체 안내렌즈 삽입술의 단기간 임상성적. 대한안과학회지. 2009;50(6):839-851.

이보 ICL의 장점(안구건조증이 걱정되세요?) - 광고심의필: 조합-2022-04-033 (유효기간: 2025.02.08)

1. Gregory D. Parkhurst, et al. Phakic Intraocular Lens Implantation in United States Military Warfighters: A Retrospective Analysis of Early Clinical Outcomes of the EVO ICL. J Refract Surg. 2011;27(7);473-481. 2. FDA. Before, During & After Surgery. https://www.fda.gov/medical-de... (as of 2021-12-24). 3. 윤재문 외. 난시교정용 후방 유수정체 안내렌즈 삽입술의 단기간 임상성적. 대한안과학회지. 2009;50(6):839-851.

이보 ICL의 장점(마치 내 눈 같은 편안함) - 광고심의필: 조합-2022-04-029 (유효기간: 2025.02.03)

1. FDA. Before, During & After Surgery. https://www.fda.gov/medical-de... (as of 2021-12-24). 2. 윤재문 외. 난시교정용 후방 유수정체 안내렌즈 삽입술의 단기간 임상성적. 대한안과학회지. 2009;50(6):839-851.

수술 과정 - 광고심의필: 조합-2022-04-034 (유효기간: 2025.02.03)

1. FDA. Before, During & After Surgery. https://www.fda.gov/medical-de... (as of 2021-12-24) 2. 윤재문 외. 난시교정용 후방 유수정체 안내렌즈 삽입술의 단기간 임상성적. 대한안과학회지. 2009;50(6):839-851. 3. Elena Martines-plaze, et al. Effect of the EVO + Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life. Am J Ophthalmol. 2021;226:117-125. 4. Data on file. STAAR Surgical Annual Report.

자주 묻는 질문 - 광고심의필: 조합-2022-04-035 (유효기간: 2025.02.03)

On the Field with Will Levis

Will Levis’ struggle with glasses and contacts

Why Will Levis chose EVO ICL lenses

주요 안전성 정보

국가 또는 지역 선택

Europe

North America

Latin America

North Africa

Middle East

Asia Pacific

참고자료

개인정보 수집 및 이용